Fate Therapeutics (FATE) Receivables - Net (2015 - 2026)
Fate Therapeutics (FATE) reported Receivables - Net of $703,000 for Q2 2026, down 49.6% from $1.4 million a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Receivables - Net (2015 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics posted Receivables - Net of $916,000, down 74.1% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of -30.2% (FY2020 to FY2025).
- By year, Receivables - Net came in at $3.54 million in FY2024 (+93.8%), $1.83 million in FY2023 (-95.3%), $38.48 million in FY2022 (+343.5%) and $8.68 million in FY2021 (+57.3%).
- Five-year quarterly Receivables - Net spans a low of $682,000 in Q3 2025 and a high of $38.48 million in Q4 2022.
- Year over year, Receivables - Net has now declined in each of the last four quarters, with growth averaging 24.7% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q4 2022 (growth of 343.5%); the low point was Q4 2023 (a decline of 95.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $704,000 (Q1 2026), $916,000 (Q4 2025) and $682,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 703,000.00 |
| Mar 31, 2026 | 704,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Sep 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 858,000.00 |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 38.48 Mn |
| Sep 30, 2022 | 10.22 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 13.85 Mn |
| Dec 31, 2021 | 8.68 Mn |
| Sep 30, 2021 | 7.31 Mn |
API Access
Fate Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();